2023
DOI: 10.1016/s1556-0864(23)00440-9
|View full text |Cite
|
Sign up to set email alerts
|

187P Tissue B-cell receptor repertoire as biomarker of complete pathological response in NSCLC patients treated with neoadjuvant chemoimmunotherapy (NADIM trials)

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles